Kostopoulou Vasiliki, Tsiatas Marinos L, Kelekis Dimitrios A, Dimopoulos Meletios-Athanasios, Papadimitriou Christos A
Department of Clinical Therapeutics, Alexandra Hospital, Athens Medical School, 80, Vas. Sofias Ave., 115 28, Athens, Greece.
Emerg Radiol. 2009 Mar;16(2):143-6. doi: 10.1007/s10140-008-0714-5. Epub 2008 Mar 6.
Port-a-cath systems are often essential for the administration of long-term chemotherapy in the treatment of malignancies because they improve venous access, but they are associated with complications, mainly thrombosis of central veins. In the present report, we describe a case of right subclavian and superior vena cava port-a-cath-related thrombosis causing superior vena cava syndrome (SVCS) in a patient affected by Hodgkin's disease. The patient underwent percutaneous revascularization with stent positioning, experiencing immediate relief of symptoms. Endovascular procedures for the treatment of nonmalignant SVCS seem to represent a challenging therapeutic option.
输液港系统对于恶性肿瘤患者长期化疗给药通常至关重要,因为它们改善了静脉通路,但也会引发并发症,主要是中心静脉血栓形成。在本报告中,我们描述了一例患有霍奇金病的患者,其右锁骨下静脉和上腔静脉输液港相关血栓形成导致上腔静脉综合征(SVCS)。该患者接受了支架置入的经皮血管重建术,症状立即缓解。血管内介入治疗非恶性SVCS似乎是一种具有挑战性的治疗选择。